DbpA antibodies and uses thereof
Embodiments of the present disclosure relate to chimeric antibodies which specifically bind to Borrelia decorin-binding protein A (DbpA) antigens and compositions or kits comprising such antibodies. The disclosure further relates to use of such antibodies in the detection of Borrelia sp. in samples, e.g., biological samples such as human blood and/or tissues of deer, ticks and other carriers of Borrelia . Embodiments of the disclosure further relate to diagnosis and/or therapy of Lyme disease using the chimeric antibodies and/or compositions containing the chimeric antibodies.
1. An antibody or an antigen-binding fragment thereof, comprising:
a variable heavy chain region (VH) comprising heavy chain complementarity-determining regions CDR H1 , CDR H2 , and CDR H3 , together with a variable light chain region (VL) comprising light chain complementarity-determining regions CDR L1 , CDR L2 , and CDR L3 ,
wherein,
CDR H1 has the amino acid sequence DYWIE (SEQ ID NO: 7);
CDR H2 has the amino acid sequence EILPGSGSTKDNERFKG (SEQ ID NO: 8);
CDR H3 has the amino acid sequence REWGYYFDY (SEQ ID NO: 9);
CDR L1 has the amino acid sequence KASQDVSTAVA (SEQ ID NO: 10);
CDR L2 has the amino acid sequence IYWASTRHT (SEQ ID NO: 11); and
CDR L3 has the amino acid sequence QQHYSTPYT (SEQ ID NO: 12).
2. The antibody or the antigen-binding fragment of claim 1 , further comprising a framework region (FR).
3. The antibody or the antigen-binding fragment of claim 1 , wherein:
(1) the variable heavy chain region (VH) comprises the sequence set forth in SEQ ID NO: 35; and
(2) the variable light chain region (VL) comprises the sequence set forth in SEQ ID NO: 36.
4. A method of detecting Borrelia burgdorferi decorin-binding protein A (DbpA)antigen in a biological sample, comprising contacting the sample with the antibody of claim 3 and detecting a complex formed between the Borrelia burgdorferi DbpA antigen and the antibody.
5. The antibody or the antigen-binding fragment thereof of claim 1 , which comprises a single chain antibody fragment (scFV), an Fab fragment, or an F(ab′)2 fragment.
6. The antibody or the antigen-binding fragment thereof of claim 1 , further comprising a linker (L).
7. The antibody or the antigen-binding fragment thereof of claim 6 , wherein the linker (L) is between the variable heavy chain region (VH) and the variable light chain region (VL).
8. The antibody or an antigen-binding fragment thereof of claim 1 , wherein the antibody or an antigen-binding fragment further comprises a signal peptide and optionally a label.
9. A kit comprising, in one or more packages, an antibody or an antigen-binding fragment of claim 8 and a container, optionally together with instructions for using the kit.